Chemoinformaics analysis of 4-Hydroxy-6, 3, 5-Triprenylisoflavonone
| Molecular Weight | 458.598 | nRot | 7 |
| Heavy Atom Molecular Weight | 424.326 | nRig | 21 |
| Exact Molecular Weight | 458.246 | nRing | 3 |
| Solubility: LogS | -4.243 | nHRing | 1 |
| Solubility: LogP | 8.057 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 68 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 34 | No. of Aromatic Carbocycles | 2 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 30 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 12 |
| nHA | 4 | APOL | 75.979 |
| nHD | 1 | BPOL | 37.581 |
| QED | 0.286 |
| Synth | 3.159 |
| Natural Product Likeliness | 0.99 |
| NR-PPAR-gamma | 0.973 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.997 |
| Pgp-sub | 0.055 |
| HIA | 0.008 |
| CACO-2 | -4.816 |
| MDCK | 0.0000176 |
| BBB | 0.007 |
| PPB | 0.872582 |
| VDSS | 3.084 |
| FU | 0.122087 |
| CYP1A2-inh | 0.609 |
| CYP1A2-sub | 0.165 |
| CYP2c19-inh | 0.884 |
| CYP2c19-sub | 0.068 |
| CYP2c9-inh | 0.879 |
| CYP2c9-sub | 0.925 |
| CYP2d6-inh | 0.166 |
| CYP2d6-sub | 0.543 |
| CYP3a4-inh | 0.184 |
| CYP3a4-sub | 0.095 |
| CL | 8.762 |
| T12 | 0.043 |
| hERG | 0.033 |
| Ames | 0.007 |
| ROA | 0.256 |
| SkinSen | 0.661 |
| Carcinogencity | 0.056 |
| EI | 0.082 |
| Respiratory | 0.126 |
| NR-Aromatase | 0.704 |
| Antiviral | Yes |
| Prediction | 0.881083 |